Queen City Angels

Queen City Angels is one of the longest-running angel networks in the Midwest, and from its Cincinnati base it has built a working pipeline of early-stage medical device and AI-driven diagnostic deals. Portfolio examples include ProSentry and Skyfire, which sit in the broader category of technical hardware and software companies addressing serious clinical or operational problems. The network functions as both a syndication mechanism and a curation layer, which matters in regional ecosystems where solo angel capital can be hard to organize coherently.

The thesis is medical devices and AI in healthcare, with a working preference for companies where the underlying technology is genuinely difficult and the clinical application is specific. AI focus is real and reflects the broader direction of diagnostics and devices toward platforms that combine sensing, hardware, and machine learning. Founders building services-heavy care delivery without a clear technical core are usually a less natural fit; technical founders working on diagnostics, sensing, and devices should find the network well-aligned.

Checks fall in the two hundred and fifty thousand to one million dollar range at pre-seed and seed, syndicated across the network rather than written from a single decision-maker. The structure means that founders engage with the network’s leadership and then with the broader membership, and the eventual check is an aggregation of individual angel commitments. Geography is centered on the Cincinnati ecosystem and the broader Midwest, with engagement extending to companies that have a credible reason to spend time in the region.

The network is a member organization rather than a fund, with a leadership team that runs the deal flow and a membership base that ultimately commits the capital. That structure shapes the engagement and the timeline.

The approach is regionally grounded and process-driven by angel-network standards. Founders should expect a structured pitch process that involves an initial screen, a deeper dive with interested members, and a syndication phase. The leverage of the network is the depth of operating experience among its members, many of whom have built and sold companies in the region’s industrial and healthcare sectors. Process timelines are slower than a single-decision-maker check but materially faster than institutional venture diligence. Follow-on participation across subsequent rounds is common when companies progress on plan, and the network often coordinates with regional institutional investors to extend runway. For technical medtech and diagnostics founders with a regional anchor or a real reason to engage with the Midwest, the fit is direct.